Commercial insight into the pharma and biotech sector.
EP Vantage is a daily news service with a difference. Powered by EvaluatePharma®, EP Vantage brings fresh angles & insight on current & future industry triggers using proprietary quantitative analysis.
Each day EP Vantage delivers forward-looking comment and analysis, focusing on events that define the commercial future of companies, products and therapy areas:
-
In-depth & incisive analysis of regulatory & patent decisions, marketing approvals, licensing deals and M&A
-
Daily EventAnalyzer alerts offer the most comprehensive daily round up of share price movements plus the story behind the news
- Timely financial analysis each day of pivotal events put into context with EvaluatePharma market data
- Advanced intelligence from Calendar of Events on potential market catalysts weeks & even months ahead of other industry sources
- Unique access to interactive NPV Analyzer to quantify the impact on product & company valuation
" Someone’s actually thought about what’s happened, as opposed to just writing about it...."
Strategy Director, European based global pharmaceutical company
Register for a FREE TRIAL of EP Vantage